The new study of emerging materials helping in detection of COVID-19

International group of scientists conducted research on the electrochemical biosensors
29-Apr-2021 11:25 AM EDT, by Ural Federal University

Newswise — The SARS-CoV-2 virus is still causing a dramatic loss of human lives worldwide, constituting an unprecedented challenge for society, public health, and economy, to overcome. Currently, SARS-CoV-2 can be diagnosed in two different ways: i) antigen tests (point-of-care, POC) and ii) molecular tests (nucleic acid, RNA, or PCR-polymerase chain reaction). Antigen tests can detect parts of SARS-CoV-2 proteins, known as antigens, via a nasopharyngeal or nasal swab sampling method. The main advantages of POC-test include the high specificity, quick response (less than an hour), and portability, with no need of fixed laboratory facilities. On the other hand, in a molecular diagnostic test, a reverse transcriptase polymerase chain reaction (RT-PCR) is evolved, also known as nucleic acid amplification method, which requires expensive laboratory equipment, hours of analysis, and special staff.

Despite the great efforts of the scientific community towards the development of diagnostic tools and the achievement of high specificity and sensitivity of the molecular tests, the concern about the control and detection of the SARS-CoV-2 remains.

The scientist of Ural Federal University, Prof. Panagiotis Tsiakaras with his colleagues in international research groups focused on reviewing the materials used for the design and development of electrochemical biosensors for the SARS-CoV-2 detection, highlighting the significant role the electrochemistry could play in controlling COVID disease. This kind of biosensors could be a successful virus diagnostic tool of high sensitivity, specificity, low cost, quick response, requiring no special personnel and offering the advantage of the portability. The Paper was published in the Journal of Electroanalytical Chemistry.

Up to date, two main groups of materials have been thoroughly explored as transducer electrodes: i) the Au (gold)-based and ii) the carbon or graphene-based ones. Both present faster response time (within a few seconds) along with higher accuracy than the current detection methods, and most of them has also higher sensitivity. Moreover, many of them have the possibility of being portable and miniaturized.

Comparing the above two groups of materials the researchers concluded that the carbon or graphene-based ones can compete the Au-based electrodes, as they have similar or better operational characteristics, also offering the advantage of lower cost.

In the current review, scientists recognize that in the case of the Au-based electrodes, the Au was mainly used in the form of nanoparticles onto alternative support (polymer-based or other) or supported onto reduced graphene oxide before being deposited onto the basic platform. The inclusion of the r-GO (reduced graphene oxide) to the Au nanoparticles significantly ameliorates SARS-CoV-2 sensor characteristics as it expands mainly the detection area that the virus binds.

In the case of carbon or graphene-based electrodes, surface functionalization constitutes the main strategy that was followed. Especially graphene and its derivatives, which are considered the most promising materials, does not contain chemically reactive functional groups that could help immobilizing analyte biomolecules. Thus, its surface or structure alteration was investigated by: i) doping graphene with another (bio)element, or ii) creating structure defects, or iii) being used as they are to modify screen-printed carbon electrodes.

Among the applied detection techniques electrochemical impedance spectroscopy, amperometry, and differential pulse voltammetry were the most used ones. Meanwhile, in the case of the amperometric technique, there is a concern about the 'real' current response of the sensor when being in an environment with high virus concentrations, as may diffusion phenomena prevail.

Electrochemical impedance spectroscopy, square wave voltammetry, and differential pulse voltammetry detection techniques are more sensitive and reliable, especially to the very low concentration values of the target analyte. However, for acquiring the 'real' charge the optimum operational conditions are set each time (Hz or voltage step, or scan rate, etc) according to the virus concentration.

Concluding their review, Prof. Panagiotis Tsiakaras and his colleagues report that: among the explored electrode materials, Au-based and carbon or graphene-based electrodes are the two main material groups, while the nanomaterial-based electrochemical biosensors could enable a fast, accurate, and without special cost, virus detection. However, as they state, it is necessary to further research to be done in terms of various nanomaterials and novel synthesis strategies in order the SARS-CoV-2 biosensors to be commercialized.



Dr Panagiotis Tsiakaras is a Professor and Head at the Department of Mechanical Engineering, School of Engineering, University of Thessaly (Volos-Greece). He also is a member of the Laboratory of Materials and Devices for Clean Energy, Department of Technology of Electrochemical Processes, Ural Federal University, and Supervisor of Laboratory of Electrochemical Devices based on Solid Oxide Proton Electrolytes, Institute of High Temperature Electrochemistry (RAS), (Yekaterinburg-Russian Federation).

Research interests: Catalytic and electrocatalytic processes; Solid state electrochemistry; Electrochemical devices for energy conversion and storage; Low -, medium-and high-temperature fuel cells; Direct alcohol fuel cells for electricity generation.

P. Tsiakaras is a co-author of more than 300 scientific papers, books, and patents, with ~14000 citations and Hirsch index = 62 (based on Google Scholar database).


Filters close

Showing results

110 of 5857
Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Newswise: First Wave COVID-19 Data Underestimated Pandemic Infections
18-Jun-2021 8:30 AM EDT
First Wave COVID-19 Data Underestimated Pandemic Infections
American Institute of Physics (AIP)

Two COVID-19 pandemic curves emerged within many cities during the one-year period from March 2020 to March 2021. Oddly, the number of total daily infections reported during the first wave is much lower than that of the second, but the total number of daily deaths reported during the first wave is much higher than the second wave.

Newswise: PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Released: 22-Jun-2021 9:55 AM EDT
PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Pacific Northwest National Laboratory

PNNL researchers used natural language processing and deep learning techniques to reveal how and why different types of misinformation and disinformation spread across social platforms. Applied to COVID-19, the team found that misinformation intended to influence politics and incite fear spreads fastest.

Released: 22-Jun-2021 8:30 AM EDT
Engineering Nanobodies As Lifesavers When SARS-CoV-2 Variants Attack
Ohio State University

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

Released: 21-Jun-2021 3:45 PM EDT
Rare Neurological Disorder Documented Following COVID-19 Vaccination
American Neurological Association (ANA)

In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barré syndrome after individuals were vaccinated against COVID-19.

Newswise: New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
17-Jun-2021 12:10 PM EDT
New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
Harvard Medical School

Risk of SARS-CoV-2 infection increased 30 percent for households with a recent birthday in counties with high rates of COVID-19 Findings suggest informal social gatherings such as birthday parties played role in infection spread at the height of the coronavirus pandemic No birthday-bash infection jumps seen in areas with low rates of COVID-19 Households with children’s birthdays had greater risk of SARS-CoV-2 infection than with adult birthdays

Newswise: COVID-19 dual-antibody therapies effective against variants in animal study
Released: 21-Jun-2021 10:05 AM EDT
COVID-19 dual-antibody therapies effective against variants in animal study
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis suggests that many, but not all, COVID-19 therapies made from combinations of two antibodies are effective against a wide range of virus variants, and that combination therapies appear to prevent the emergence of drug resistance.

Showing results

110 of 5857